MacroGenics
MGNX
#8419
Rank
NZ$0.39 B
Marketcap
NZ$6.17
Share price
4.65%
Change (1 day)
187.93%
Change (1 year)

MacroGenics (MGNX) - Cash on Hand

Cash on Hand as of September 2025 : NZ$0.25 Billion

According to MacroGenics's latest financial reports the company has NZ$0.25 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

MacroGenics - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.35 B-1.6%
2023-12-31NZ$0.36 B49.48%
2022-12-31NZ$0.24 B-31.84%
2021-12-31NZ$0.35 B-5.57%
2020-12-31NZ$0.37 B17.9%
2019-12-31NZ$0.32 B-7.72%
2018-12-31NZ$0.34 B-19.2%
2017-12-31NZ$0.42 B7.44%
2016-12-31NZ$0.39 B-19.28%
2015-12-31NZ$0.49 B146.3%
2014-12-31NZ$0.20 B41.9%
2013-12-31NZ$0.14 B144.24%
2012-12-31NZ$58.03 M-17.97%
2011-12-31NZ$70.75 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
NZ$23.28 B 9,187.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$12.45 B 4,864.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.63 B 6,135.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$16.46 B 6,466.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$24.94 B 9,848.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$18.28 B 7,190.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$0.93 B 274.14%๐Ÿ‡บ๐Ÿ‡ธ USA